Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06852950 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
A NA study of Hyperglycemia and Type 2 Diabetes Mellitus (T2DM), sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06852950: Recruiting NA study of Hyperglycemia and Type 2 Diabetes Mellitus (T2DM), sponsored by Vanderbilt University Medical Center.
NCT06852950 is a NA study of Hyperglycemia and Type 2 Diabetes Mellitus (T2DM) that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 60 participants, below the 877-participant average among 38 other Hyperglycemia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06852950, a NA study of Hyperglycemia and Type 2 Diabetes Mellitus (T2DM), is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.
Primary Outcome
Questionnaire responses regarding patient satisfaction and opinion regarding use of continuous glucose monitoring system: regarding how do subjects feel that using CGM impacted their glucose control on a scale of 1-5, with 1=strongly made it worse, 2=somewhat made it worse, 3=did not make it better or worse, 4=somewhat made it better, and 5=strongly made it better?; regarding what is the overall opinion of subject's experience with CGM use on a scale of 1-5, with 1=very negative, 2=negative, 3=n
Conditions Studied
Interventions
- DEVICE Libre 3 Plus Continuous Glucose Monitor
- DEVICE Dexcom G7 Continuous Glucose Monitor
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-03-09 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT06852950 shows while recruiting
NCT06852950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 877-participant average among 38 other Hyperglycemia trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Hyperglycemia appearing as the primary indexed condition, and to 2 interventions - of which Libre 3 Plus Continuous Glucose Monitor is the first listed.
NCT06852950 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06852950 about?
NCT06852950 is a clinical study titled "Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge". This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting ...
What is the current status of trial NCT06852950?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-09. Estimated completion is 2027-01.
What conditions does trial NCT06852950 study?
This clinical trial studies the following conditions: Hyperglycemia, Type 2 Diabetes Mellitus (T2DM), Type 1 Diabetes Mellitus (T1DM).
What interventions are being tested in trial NCT06852950?
The interventions under investigation include: Libre 3 Plus Continuous Glucose Monitor (DEVICE), Dexcom G7 Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT06852950?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06852950 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06852950's enrollment target sits among peer trials
60 18th of 38 higher than 21 of 38 other Hyperglycemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperglycemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
-
Time to Move in Pregnancy Hyperglycemia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI